Advos

The widely cited $360,000 median home price in Tucson fails to reflect the reality of individual neighborhoods, leading buyers and sellers to make costly mistakes, according to real estate veteran Tony Ray Baker.

Lotto.com's $3.1 million New York Lotto jackpot win marks the platform's highest prize of 2026 and second-largest ever, highlighting the growing role of online lottery couriers in delivering major wins.

AZIO AI Holdings gains recognition for its Atlas One project as the AI industry's growing electricity demand makes contracted power capacity a key metric for investors.

CHORD Real Estate’s Invest Panama Summit reveals a modern, business-friendly Panama that surprises North American investors, prompting a third event in January 2027.

Outamation and Extern's AI externships trained 4,046 students from 59 countries in practical mortgage document automation, addressing the growing employer demand for AI-ready talent.

Wearable Devices Ltd. will present its Mudra Studio Evaluation Kit at the Augmented Enterprise Summit 2026, offering enterprises a new tool to develop and test touchless controls for smart glasses and XR applications.

The FAA's eVTOL Integration Pilot Program is prioritizing medical, logistics, and cargo operations over passenger air taxis, with early flights already underway and significant implications for infrastructure and rural communities.

Samsung has secured long-term supply contracts for 80% of its 2027 memory chip production, as AI demand outstrips supply, potentially reshaping the tech supply chain and benefiting major customers like Nvidia.

A new CGTN report details how Gari Village in China's Dawagengzha scenic area leveraged a mountain road to build a thriving tourism economy, offering a model for rural development.

Jaguar has introduced its first fully electric vehicle in the United States, the Type 01, as part of a bold rebranding effort to attract affluent, technology-focused customers.

A UK study has identified a potential method to halt lung cancer in its early stages by eliminating 'immune fog,' but residual cancer in some mice suggests advanced immunotherapies are still needed.

The U.S. crypto industry must decide whether to punish Senate Democrats for blocking a major crypto bill or preserve bipartisan relationships, with major implications for regulation and companies like Riot Blockchain.

Europe's electric vehicle market is rapidly democratizing, with sales of battery-electric vehicles jumping 45% in the first eight months of 2026, driven by a wave of affordable models that could expand access for millions of drivers.

Rail Vision Ltd. will present its AI-driven railway safety systems, including new products YardFlow and TrackScout, at the 20th Annual LD Micro Main Event, highlighting commercial progress and North American expansion.

Danish Ørsted and Spanish Moeve demonstrate how deep organizational change can drive successful shifts to clean energy, offering lessons for fossil-fuel businesses worldwide.

US stocks hit all-time highs last week as AI-driven demand for tech shares remained strong, but geopolitical risks in the Middle East could test the rally's durability.

A new report forecasts that nickel and copper prices could nearly double by 2035 due to structural supply limitations, with significant implications for manufacturers and mining companies.

The Broadway Company, in partnership with Parkstone Communities, has acquired Heathermoor Estates, a 116-lot manufactured housing community in Moody, Alabama, signaling continued investment in the asset class and providing affordable housing options near Birmingham.

NextPlat Corp opens a new PharmcoRx community pharmacy in Jacksonville, Florida, expanding its healthcare operations and targeting higher-margin contracted services.

Nutriband Inc. has raised approximately $1.75 million through warrant exercises, funds it will use to support clinical development and a New Drug Application for its AVERSA Fentanyl patch, a potential first-of-its-kind abuse-deterrent opioid product.

Scinai Immunotherapeutics' CDMO subsidiary signs a $5.1 million development and clinical manufacturing deal with a U.S. biopharma, driving committed customer orders to $7.6 million, up 300% from year-end 2025.